Bovalto Respi 3
For active immunisation of cattle in the absence of maternally derived antibodies against:
parainfluenza 3 virus, to reduce virus excretion due to infection
bovine respiratory syncytial virus, to reduce virus excretion due to infection
Mannheimia haemolytica serotype A1, to reduce clinical signs and lung lesions.
Onset of immunity (demonstrated by challenge):
3 weeks after primary...
Bovalto Respi 4
For active immunisation of cattle in the absence of maternally derived antibodies against:
parainfluenza 3 virus, to reduce virus excretion due to infection
bovine respiratory syncytial virus, to reduce virus excretion due to infection
bovine viral diarrhoea virus, to reduce virus excretion due to infection
Mannheimia haemolytica serotype A1, to reduce clinical signs and lung lesions.
Onset...
Bovalto Respi Intranasal
For the active immunisation of calves from the age of 10days against bovine respiratory syncytial virus (BRSV) and bovine parainfluenza 3 virus (PI3V), to reduce the quality and duration of nasal excretion of both viruses.
Onset of immunity - 10days after vaccine
Duration of immunity - 12 weeks after vaccination
Bovilis Bovipast RSP 10 dose
For the active immunisation of cattle against
Parainfluenza3 virus (PI3 virus), to reduce infections.
Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs.
Mannheimia (Pasteurella) haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6. Cross-reactive immunity to the...
Bovilis Intranasal RSP Live
For active immunisation of calves from the age of 1 week old onwards to reduce clinical signs of respiratory disease and viral shedding from infection with BRSV and PI3.
Onset of immunity:
BRSV: 5 days
PI3: 1 week
Duration of immunity: 12 weeks
Hiprabovis Somni/Lkt
To reduce the clinical signs and lung lesions caused by Mannheimia haemolytica serotype A1 and Histophilus somni in calves from 2 months of age.
Nasym IN / IM RSV Vaccine
For the active immunisation of cattle to reduce virus shedding and respiratory clinical signs caused by bovine respiratory syncytial virus infection.
Onset of immunity:
21 days after administration of one dose by the nasal route.
21 days after the second dose of the two dose intramuscular vaccination schedule.
Duration of immunity:
2 months after nasal vaccination.
6 months...
Rispoval 3 5 dose
For the active immunisation of calves from 12 weeks of age to:
Reduce virus excretion and the clinical signs caused by PI3 virus
Reduce virus excretion caused by BRSV infection, reduce virus excretion and the severity of leucopenia induced by BVDV type 1 infection
Onset of immunity: 3 weeks after vaccination.
Duration of immunity: 6 months (demonstrated by challenge studies) after vaccination...
Rispoval 4 5 dose
For active immunisation of cattle to reduce infection, clinical signs and respiratory disease caused by
Bovine Respiratory Synctial Virus (BRSV),
Infectious Bovine Rhinotracheitis (IBR, caused by BHV-1) virus
Parainfluenza type 3 Virus (PI3); and leucopenia and viraemia caused by the Bovine Viral Diarrhoea (BVD) virus Type 1 cytopathic and non-cytopathic strains.
A duration of immunity...
Rispoval Intranasal RS + PI3
For active immunisation of maternally derived antibody positive or negative calves from 9 days of age against BRSV and PI3V, to reduce the mean titre and duration of excretion of both viruses.
Onset of immunity: 5 days for BRSV and 10 days for PI3V after a single vaccination.
Duration of protective immunity: 12 weeks following a single dose. The duration of protective immunity against the PI3V...
Rispoval Pasteurella
For the active immunisation of cattle to reduce lesions and respiratory disease caused by Pasteurella haemolytica biotype A, serotype 1.
Studies carried out show that a single dose is sufficient to confer protection from challenge by Pasteurella haemolytica within 7 days of vaccination.
The vaccine will protect animals for at least 17 weeks.